In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 28th, 2009 | 12 | Yes |
Popular Name: (4R,4aR,8aR)-4-methyl-3,4,4a,5,6,7,8,8a-octahydroquinolin-2-amine (4R,4aR,8aR)-4-methyl-3,4,4a,5,6…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.30 | 4.1 | -29.34 | 3 | 2 | 1 | 40 | 167.276 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
PUBCHEM_PATENT_ID | EP0789571A1; US5629322; WO1996014844A1 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
NOS1-4-E | Nitric-oxide Synthase, Brain (cluster #4 Of 7), Eukaryotic | Eukaryotes | 53 | 0.85 | Binding ≤ 10μM |
NOS2-1-E | Nitric Oxide Synthase, Inducible (cluster #1 Of 9), Eukaryotic | Eukaryotes | 22 | 0.89 | Binding ≤ 10μM |
NOS3-1-E | Nitric Oxide Synthase, Endothelial (cluster #1 Of 7), Eukaryotic | Eukaryotes | 830 | 0.71 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
NOS2_HUMAN | P35228 | Nitric Oxide Synthase, Inducible, Human | 22 | 0.89 | Binding ≤ 1μM |
NOS1_HUMAN | P29475 | Nitric-oxide Synthase, Brain, Human | 53 | 0.85 | Binding ≤ 1μM |
NOS3_HUMAN | P29474 | Nitric-oxide Synthase, Endothelial, Human | 830 | 0.71 | Binding ≤ 1μM |
NOS2_HUMAN | P35228 | Nitric Oxide Synthase, Inducible, Human | 22 | 0.89 | Binding ≤ 10μM |
NOS1_HUMAN | P29475 | Nitric-oxide Synthase, Brain, Human | 53 | 0.85 | Binding ≤ 10μM |
NOS3_HUMAN | P29474 | Nitric-oxide Synthase, Endothelial, Human | 830 | 0.71 | Binding ≤ 10μM |
Description | Species |
---|---|
eNOS activation | |
Nitric oxide stimulates guanylate cyclase | |
NOSIP mediated eNOS trafficking | |
NOSTRIN mediated eNOS trafficking | |
Phagosomal maturation (early endosomal stage) | |
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | |
VEGFR2 mediated vascular permeability |